Journal of Clinical Investigation,
Journal Year:
2023,
Volume and Issue:
133(19)
Published: Oct. 1, 2023
Alveolar
macrophages
(AMs)
are
the
sentinel
cells
of
alveolar
space,
maintaining
homeostasis,
fending
off
pathogens,
and
controlling
lung
inflammation.
During
acute
injury,
AMs
orchestrate
initiation
resolution
inflammation
in
order
to
ultimately
restore
homeostasis.
This
central
role
makes
attractive
targets
for
therapeutic
interventions.
Single-cell
RNA-Seq
spatial
omics
approaches,
together
with
methodological
advances
such
as
generation
human
from
pluripotent
stem
cells,
have
increased
understanding
ontogeny,
function,
plasticity
during
infectious
sterile
inflammation,
which
could
move
field
closer
clinical
application.
However,
proresolution
phenotypes
might
conflict
proinflammatory
antibacterial
responses.
Therefore,
targeting
at
vulnerable
time
points
over
course
injury
harbor
risk
serious
side
effects,
loss
host
defense
capacity.
Thus,
identification
key
signaling
hubs
that
determine
functional
fate
decisions
is
utmost
importance
harness
their
potential.
Nature Medicine,
Journal Year:
2023,
Volume and Issue:
29(6), P. 1563 - 1577
Published: June 1, 2023
Single-cell
technologies
have
transformed
our
understanding
of
human
tissues.
Yet,
studies
typically
capture
only
a
limited
number
donors
and
disagree
on
cell
type
definitions.
Integrating
many
single-cell
datasets
can
address
these
limitations
individual
the
variability
present
in
population.
Here
we
integrated
Human
Lung
Cell
Atlas
(HLCA),
combining
49
respiratory
system
into
single
atlas
spanning
over
2.4
million
cells
from
486
individuals.
The
HLCA
presents
consensus
re-annotation
with
matching
marker
genes,
including
annotations
rare
previously
undescribed
types.
Leveraging
diversity
individuals
HLCA,
identify
gene
modules
that
are
associated
demographic
covariates
such
as
age,
sex
body
mass
index,
well
changing
expression
along
proximal-to-distal
axis
bronchial
tree.
Mapping
new
data
to
enables
rapid
annotation
interpretation.
Using
reference
for
study
disease,
shared
states
across
multiple
lung
diseases,
SPP1
Immunity,
Journal Year:
2021,
Volume and Issue:
54(6), P. 1257 - 1275.e8
Published: May 16, 2021
The
kinetics
of
the
immune
changes
in
COVID-19
across
severity
groups
have
not
been
rigorously
assessed.
Using
immunophenotyping,
RNA
sequencing,
and
serum
cytokine
analysis,
we
analyzed
serial
samples
from
207
SARS-CoV2-infected
individuals
with
a
range
disease
severities
over
12
weeks
symptom
onset.
An
early
robust
bystander
CD8+
T
cell
response,
without
systemic
inflammation,
characterized
asymptomatic
or
mild
disease.
Hospitalized
had
delayed
responses
inflammation
that
was
already
evident
near
onset,
indicating
immunopathology
may
be
inevitable
some
individuals.
Viral
load
did
correlate
this
pathological
response
but
subsequent
severity.
Immune
recovery
is
complex,
profound
persistent
cellular
abnormalities
severe
correlating
altered
inflammatory
responses,
signatures
associated
increased
oxidative
phosphorylation
replacing
those
driven
by
cytokines
tumor
necrosis
factor
(TNF)
interleukin
(IL)-6.
These
late
immunometabolic
defects
clinical
implications.
Frontiers in Immunology,
Journal Year:
2021,
Volume and Issue:
12
Published: March 25, 2021
Strong
evidence
has
been
accumulated
since
the
beginning
of
COVID-19
pandemic
that
neutrophils
play
an
important
role
in
pathophysiology,
particularly
those
with
severe
disease
courses.
While
originally
considered
to
be
a
rather
homogeneous
cell
type,
recent
attention
uncovered
their
fascinating
transcriptional
and
functional
diversity
as
well
developmental
trajectories.
These
new
findings
are
better
understand
many
facets
neutrophil
involvement
not
only
but
also
other
acute
or
chronic
inflammatory
diseases,
both
communicable
non-communicable.
Here,
we
highlight
observed
immune
deviation
summarize
several
promising
therapeutic
attempts
precisely
target
reactivity
patients
COVID-19.
Frontiers in Immunology,
Journal Year:
2021,
Volume and Issue:
12
Published: July 21, 2021
COVID-19
is
a
contagious
viral
disease
caused
by
SARS-CoV-2
that
led
to
an
ongoing
pandemic
with
massive
global
health
and
socioeconomic
consequences.
The
characterized
primarily,
but
not
exclusively,
respiratory
clinical
manifestations
ranging
from
mild
common
cold
symptoms,
including
cough
fever,
severe
distress
multi-organ
failure.
Macrophages,
heterogeneous
group
of
yolk-sac
derived,
tissue-resident
mononuclear
phagocytes
complex
ontogeny
present
in
all
mammalian
organs,
play
critical
roles
developmental,
homeostatic
host
defense
processes
tissue-dependent
plasticity.
In
case
infection,
they
are
responsible
for
early
pathogen
recognition,
initiation
resolution
inflammation,
as
well
repair
tissue
damage.
Monocytes,
bone-marrow
derived
blood-resident
phagocytes,
recruited
under
pathological
conditions
such
infections
the
affected
defend
organism
against
invading
pathogens
aid
efficient
inflammation.
Given
their
pivotal
function
potential
danger
posed
dysregulated
hyperinflammation,
understanding
monocyte
macrophage
phenotypes
key
tackling
disease's
mechanisms.
Here,
we
outline
current
knowledge
on
monocytes
macrophages
homeostasis
summarize
concepts
findings
role
COVID-19.
While
blood
patients
moderate
inflammatory,
interferon-stimulated
gene
(ISG)-driven
phenotype,
cellular
dysfunction
epitomized
loss
HLA-DR
expression
induction
S100
alarmin
dominant
feature
disease.
Pulmonary
infiltrating
inflammatory
hyperactivated
state
resulting
detrimental
loop
pro-inflammatory
cytokine
release
recruitment
cytotoxic
effector
cells
thereby
exacerbating
damage
at
site
infection.
Cell,
Journal Year:
2021,
Volume and Issue:
184(19), P. 4953 - 4968.e16
Published: Aug. 19, 2021
Severe
coronavirus
disease
2019
(COVID-19)
is
characterized
by
overproduction
of
immune
mediators,
but
the
role
interferons
(IFNs)
type
I
(IFN-I)
or
III
(IFN-III)
families
remains
debated.
We
scrutinized
production
IFNs
along
respiratory
tract
COVID-19
patients
and
found
that
high
levels
IFN-III,
to
a
lesser
extent
IFN-I,
characterize
upper
airways
with
viral
burden
reduced
risk
severity.
Production
specific
not
members
denotes
mild
pathology
efficiently
drives
transcription
genes
protect
against
severe
acute
syndrome
2
(SARS-CoV-2).
In
contrast,
compared
subjects
other
infectious
noninfectious
lung
pathologies,
are
overrepresented
in
lower
exhibit
gene
pathways
associated
increased
apoptosis
decreased
proliferation.
Our
data
demonstrate
dynamic
SARS-CoV-2-infected
show
play
opposing
roles
at
distinct
anatomical
sites.
Nature Communications,
Journal Year:
2021,
Volume and Issue:
12(1)
Published: July 5, 2021
Epidemiological
and
clinical
reports
indicate
that
SARS-CoV-2
virulence
hinges
upon
the
triggering
of
an
aberrant
host
immune
response,
more
so
than
on
direct
virus-induced
cellular
damage.
To
elucidate
immunopathology
underlying
COVID-19
severity,
we
perform
cytokine
multiplex
profiling
in
patients.
We
show
hypercytokinemia
differs
from
interferon-gamma-driven
storm
macrophage
activation
syndrome,
is
pronounced
critical
versus
mild-moderate
COVID-19.
Systems
modelling
levels
paired
with
deep-immune
shows
classical
monocytes
drive
this
hyper-inflammatory
phenotype
a
reduction
T-lymphocytes
correlates
disease
CD8+
cells
being
disproportionately
affected.
Antigen
presenting
machinery
expression
also
reduced
disease.
Furthermore,
report
neutrophils
contribute
to
severity
local
tissue
damage
by
amplification
formation
neutrophil
extracellular
traps.
Together
our
findings
suggest
myeloid-driven
immunopathology,
which
hyperactivated
ineffective
adaptive
system
act
as
mediators
severity.